Liberyx Therapeutics is an innovative clinical-stage biopharma combating rare pediatric neurometabolic disorders. We are focused on developing safe, patient-friendly treatments for neurometabolic disorders such as nonketotic hyperglycinemia (NKH) and urea cycle disorders (UCD).
Company Details
- Founded
- -
- Industry
- Biotechnology
- Website
- https://liberyxtherapeutics.com/
Liberyx Therapeutics Questions
Liberyx Therapeutics's website is https://liberyxtherapeutics.com/
Liberyx Therapeutics's LinkedIn profile is https://www.linkedin.com/company/liberyxtherapeutics
Liberyx Therapeutics's industry is
Biotechnology
Liberyx Therapeutics's top competitors are
Cytovant Sciences Co., Ltd.,
Ssygroup,
Regent Pacific Group(Hk)ltd.,
广州市恒诺康医药科技有限公司,
Shenzhen Zhenrui Biotech Co., Ltd,
Polaryx Therapeutics,
Pentsao Fund Lp,
Shenzhen Sinoplant Biotech Ltd,
Shenzhen Finder Biotech Co., Ltd.,
Uni-Bio Science Group (Hk690) 联康生物科技集团.
Liberyx Therapeutics's categories are Biotechnology
Liberyx Therapeutics's founding year is 2021
